Building 11 and Water Towers Renovation at the National Center for Toxicological Research Jefferson Labs Complex

The U.S. Food and Drug Administration (FDA) is conducting market research to support the Office of Facilities Engineering and Mission Support Services (OFEMS) requirement for Building 11 and Water Towers Renovation at the National Center for Toxicological Research Jefferson Labs Complex. The project involves renovation and repair of building 11 and water towers, including asbestos testing, roof replacement, and refurbishment of water tanks. The FDA is seeking sources to determine the availability and capability of businesses for the provision of the required services. • The project requires a range of construction services, including demolition, renovation, and repair of building 11 and water towers. • The project involves working with asbestos, which requires specialized handling and removal. • The FDA is seeking capability statements from interested parties, which should include information on the company's experience, qualifications, and past performance. • The project is estimated to have a magnitude of $5-10 million and a period of performance of 36 months.